Focus on knowledge creation

Without ideas there is nothing to manage
SYNAPSE – Facts and Figures

SYNAPSE – Facts and Figures

Ten years ago Innovative Medicines Initiative Joint Undertaking (IMI-JU) was created as a unique public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) aiming to accelerate...

ADVANCE BLUEPRINT IS OPEN FOR PUBLIC CONSULTATION

ADVANCE BLUEPRINT IS OPEN FOR PUBLIC CONSULTATION

Vaccines undergo rigorous testing prior to licensing for use, however it is important that the safety of vaccines is monitored on an ongoing basis. The ADVANCE project, managed by Synapse and sponsored by the Innovative Medicines Initiative Joint Undertaking (IMI JU)...